Search results for "Side effects"


 
Results 21 - 30 of about 452 for "Side effects".
Sort by: Relevance | Newest | Oldest

New findings on antiviral flu treatment

A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://immattersacp.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023

DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis

A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://immattersacp.org/weekly/archives/2023/01/03/5.htm
3 Jan 2023

Updated advice on anxiety screening

The U.S. Preventive Services Task Force recently concluded that for adults up to age 65 years, including those who are pregnant or postpartum, screening for anxiety is beneficial and should be conducted routinely in primary care.
https://immattersacp.org/archives/2023/10/updated-advice-on-anxiety-screening.htm
1 Oct 2023

Separate industry-funded studies find benefit to bempedoic acid as preventive medication, CRP as biomarker

Bempedoic acid reduced cardiovascular (CV) events among patients unwilling or unable to take statins, a trial found, while a review showed that high-sensitivity C-reactive protein (CRP) was a stronger predictor for risk of future CV events and death than cholesterol in patients on statins.
https://immattersacp.org/weekly/archives/2023/03/14/4.htm
14 Mar 2023

Warning on an antipsychotic; generic rosuvastatin approval

This update covers new warnings on the entire class of opioids and approval of the first leadless pacemaker approved to treat heart rhythm disorders.
https://immattersacp.org/archives/2016/06/fda.htm
1 Jun 2016

Updated warning issued on risks of fluoroquinolones

Fluoroquinolone use for sinusitis, bronchitis, and uncomplicated urinary tract infections should be reserved for patients who do not have alternative treatment options, according to an FDA safety communication.
https://immattersacp.org/weekly/archives/2016/05/24/5.htm
24 May 2016

Warning on IBS drug for patients without gallbladders

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/05/fda.htm
1 May 2017

Aiding patients' decisions on PSA screening

Routine prostate-specific antigen (PSA) screening of all men over a certain age began about 20 years ago, but the certainty about whether that was or is wise medical practice is long gone.
https://immattersacp.org/archives/2011/07/prostate.htm
1 Jul 2011

Debates tackle clinical relevance of GI disorders

The conditions of ineffective esophageal motility and eosinophilic esophagitis underwent debate between experts about their clinical significance and best management practices.
https://immattersacp.org/archives/2021/07/debates-tackle-clinical-relevance-of-gi-disorders.htm
1 Jul 2021

Managing superbugs in your community

General internists are poised to assume a key role in tackling the increasingly formidable threat of antimicrobial resistance.
https://immattersacp.org/archives/2017/05/superbugs.htm
1 May 2017

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next